Original Literature | Model OverView |
---|---|
Publication
Title
Distinct functions of IRF-3 and IRF-7 in IFN-alpha gene regulation and controlof anti-tumor activity in primary macrophages.
Affiliation
Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research,McGill University, Montreal, Canada H3T 1E2.
Abstract
Type I IFN (IFN-alpha/beta) have important biological functions ranging fromimmune cell development and activation, to tumor cell killing and mostimportantly inhibition of virus replication. Following viral infection oractivation of Toll-like receptors (TLRs) via distinct ligands, IFN-alpha/betaare produced. Two members of the interferon regulatory factor (IRF) family -IRF-3 and IRF-7 - are the major modulators of IFN gene expression. Activation ofIRF-3 and IRF-7 by TBK1/IKKvarepsilon mediated phosphorylation promotes IFN geneexpression and potentiates the production of IFN responsive genes important tothe development of an effective antiviral immune response. IFN treatment canaugment anti-tumor properties and they are potentially key players in cancertherapy. For example, adoptive transfer of IFN-gamma-activated macrophages canmediate tumor cell killing via direct cell-cell contact, as well as release ofsoluble cytotoxic pro-inflammatory molecules. A recent study investigatedwhether IRF-3 and IRF-7 could mediate the acquisition of new anti-tumor effectorfunctions in macrophages. Adenovirus mediated transduction of the active form ofIRF-7 into primary macrophages resulted in the production of type I IFN,upregulation of target genes including TRAIL and increased tumoricidal activityof macrophages; in contrast, the active form of IRF-3 led to induction of celldeath. These studies indicate that IRF-7 transduced macrophages may be anattractive candidate for in vivo adoptive therapy of cancer.
PMID
16846591
|
Entity
csml-variable:Double
m87546
10
infinite
0
Affymetrix | 1666_at |
Ensembl | ENSG00000197919 |
HGNC | IFNA13 |
OMIM | 147660 |
Proteome | HumanPSD/IFNA1 |
RefSeq | NM_024013 |
TRANSFAC | G000307 |
Unigene | Hs.37026 |
--
csml-variable:Double
m92400
10
infinite
0
Affymetrix | 101789_i_at |
Ensembl | ENSMUSG00000070904 |
MGD | Ifna4 |
Proteome | HumanPSD/Ifna4 |
RefSeq | NM_010504 |
TRANSFAC | G009107 |
Unigene | Mm.377088 |
--
IFN-beta
--
G010228
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93217
10
infinite
0
TRANSFAC | G010228 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m36
10
infinite
0
TRANSPATH | MO000000058 |
--
IKK-alpha
--
MO000000210
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m181
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000000210 |
--
IRF-7
--
MO000007702
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m980
10
infinite
0
TRANSPATH | MO000007702 |
--
IRAK-4
--
MO000039077
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m17258
10
infinite
0
TRANSPATH | MO000039077 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
IRF-7{p}
--
MO000041457
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19325
10
infinite
0
TRANSPATH | MO000041457 |
--
csml-variable:Double
m155901
10
infinite
0
Affymetrix | 220146_at |
Ensembl | ENSG00000196664 |
HGNC | TLR7 |
OMIM | 300365 |
Proteome | HumanPSD/TLR7 |
RefSeq | NM_016562 |
TRANSPATH | MO000042127 |
Unigene | Hs.102488 |
UniProt | Q9NYK1 |
--
IFNalpha1(h)
--
MO000116973
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360227
10
infinite
0
Affymetrix | 1666_at |
Ensembl | ENSG00000197919 |
HGNC | IFNA13 |
InterPro | IPR000471 |
OMIM | 147660 |
Proteome | HumanPSD/IFNA1 |
RefSeq | NM_024013 |
TRANSPATH | MO000116973 |
Unigene | Hs.37026 |
UniProt | P01562 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
IFNgamma:TypeII IFN receptor
--
e10
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m10
0
infinite
0
--
ISGs
--
e11
cso30:c:mRNA
cso30:i:CC_NuclearChromosome
--
csml-variable:Double
m11
0
infinite
0
--
RNase L
--
e12
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
OAS
--
e13
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m13
0
infinite
0
--
--
e14
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeMembrane
--
--
--
csml-variable:Double
m14
0
infinite
0
--
--
e15
cso30:c:EntityBiologicalCompartment
cso30:i:CC_EndosomeLumen
--
--
--
csml-variable:Double
m15
0
infinite
0
--
--
e16
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Endosome
--
--
--
csml-variable:Double
m16
0
infinite
0
--
LPS:TLR4
--
e17
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m17
0
infinite
0
--
IRF-3{p}:IRF-3{p}
--
e19
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m19
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
IRF-3{p}:IRF-3{p}
--
e20
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m20
0
infinite
0
--
IRF-3{p}:IRF-3{p}:CBP
--
e21
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m21
0
infinite
0
--
IFNalpha1:Type I IFN receptor
--
e22
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m22
0
infinite
0
--
JAK
--
e23
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m23
0
infinite
0
--
JAK{active}
--
e24
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m24
0
infinite
0
--
IRF-7{p}:IRF-7{p}
--
e26
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m26
0
infinite
0
--
IRF-7{p}:IRF-3{p}
--
e27
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m27
0
infinite
0
--
IRF-7{p}:IRF-7{p}
--
e28
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m28
0
infinite
0
--
IRF-7{p}:IRF-3{p}
--
e29
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m29
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
IFN-alpha
--
e30
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m30
0
infinite
0
--
IRF-7{p}:IRF-7{p}:IFN-alpha
--
e31
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m31
0
infinite
0
--
IRF-7{p}:IRF-3{p}:IFN-alpha
--
e32
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m32
0
infinite
0
--
IFN-alpha
--
e33
cso30:c:mRNA
cso30:i:CC_Extracellular
--
csml-variable:Double
m33
0
infinite
0
--
FCgammaR
--
e34
cso30:c:mRNA
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
TRAIL
--
e35
cso30:c:mRNA
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m35
0
infinite
0
--
NF-kappaB{active}
--
e36
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m38
10
infinite
0
TRANSPATH | MO000000058 |
--
IL-1
--
e37
cso30:c:mRNA
cso30:i:CC_Extracellular
--
csml-variable:Double
m37
0
infinite
0
--
CpG DNA
--
e39
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m41
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
TLR9:CpG DNA
--
e40
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m42
0
infinite
0
--
ssRNA
--
e41
cso30:c:Rna
cso30:i:CC_Extracellular
--
csml-variable:Double
m43
0
infinite
0
--
ssRNA:TLR7
--
e42
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m44
0
infinite
0
--
ssRNA:TLR8
--
e43
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m45
0
infinite
0
--
TLR9:CpGDNA:MyD88
--
e44
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m46
0
infinite
0
--
ssRNA:TLR7:MyD88
--
e45
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m47
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAK-4:IRF-7:TRAF6
--
e46
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m48
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK-4:IRF-7:TRAF6
--
e47
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m49
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAK-4:IRF-7:TRAF6:IKK-alpha
--
e48
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m63
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK-4:IRF-7:TRAF6:IKK-alpha
--
e49
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m64
0
infinite
0
--
IFNalpha
--
e5
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
Type I IFN receptor
--
e6
cso30:c:Protein
cso30:i:CC_Extracellular
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
TLR9:CpGDNA:MyD88:IRAK-4:IRF-7{p}:TRAF6:IKK-alpha
--
e63
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m65
0
infinite
0
--
TLR7:ssRNA:MyD88:IRAK-4:IRF-7{p}:TRAF6:IKK-alpha
--
e64
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m66
0
infinite
0
--
ISGF3
--
e65
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m67
0
infinite
0
--
PKR
--
e66
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m68
0
infinite
0
--
ISGF3:PKR
--
e67
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m69
0
infinite
0
--
OAS
--
e68
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m70
0
infinite
0
--
ISGF3:OAS
--
e69
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m71
0
infinite
0
--
IFNbeta:Type I IFN receptor
--
e7
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m7
0
infinite
0
--
IRF-7
--
e70
cso30:c:Dna
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m72
0
infinite
0
--
ISGF3:IRF-7
--
e71
cso30:c:Complex
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m73
0
infinite
0
--
IFNalpha:Type I IFN receptor
--
e8
cso30:c:Complex
cso30:i:CC_Extracellular
--
csml-variable:Double
m8
0
infinite
0
--
Type II IFN receptor
--
e9
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c2 : 1
stoichiometry:c1 : 1
stoichiometry:c3 : 1
m6*m1636*0.1
nodelay
--
0
PMID: 16846592,15864272 The IFN proteins group into two classes: type I (IFN-greek small letter alpha and -¦Â) and type II (IFN-¦Ã), which bind two distinct cell surface receptors, type I and type II IFN receptors, respectively PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p9
p10
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c24 : 1
stoichiometry:c25 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
p11
p11
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c26 : 1
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m17*m977*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun PMID: 16846591 The production of IFN-¦Â relies in part on the C-terminal phosphorylation and activation of the cytoplasmic interferon regulatory factor (IRF)-3 transcription factor PMID: 16846591 he C-terminal region comprises a cluster of phosphoacceptor sites 382GGASSLENTVDLHISNSHPLSLTSDQYKAYLQD414 and virus-induced phosphorylation is thought to realign the C-terminal domain and relieve autoinhibition
p11
p12
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m19314*m977*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun PMID: 16846591 The production of IFN-¦Â relies in part on the C-terminal phosphorylation and activation of the cytoplasmic interferon regulatory factor (IRF)-3 transcription factor PMID: 16846591 he C-terminal region comprises a cluster of phosphoacceptor sites 382GGASSLENTVDLHISNSHPLSLTSDQYKAYLQD414 and virus-induced phosphorylation is thought to realign the C-terminal domain and relieve autoinhibition
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c33 : 1
m18*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
m19*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c36 : 1
stoichiometry:c37 : 1
stoichiometry:c38 : 1
m20*m2282*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c39 : 1
stoichiometry:c40 : 1
m21*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m21*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
m21*0.1
nodelay
--
0
PMID: 16846591 Once phosphorylated, IRF-3 dimerizes and translocates to the nucleus, associates with CREB binding protein (CBP/p300) co-activators and participates in the transcriptional activation of the IFN-¦Â and human IFN-alpha1 (or murine IFN-alpha4) promoters
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
m19325*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m5*m6*0.1
nodelay
--
0
PMID: 16846592,15864272 The IFN proteins group into two classes: type I (IFN-greek small letter alpha and -¦Â) and type II (IFN-¦Ã), which bind two distinct cell surface receptors, type I and type II IFN receptors, respectively
p20
p20
cso30:i:ME_Translation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m93217*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p20
p21
cso30:i:ME_Translation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
m87546*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p22
p22
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c50 : 1
stoichiometry:c51 : 1
m6*m360227*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
stoichiometry:c54 : 1
m7*m23*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p23
p24
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c56 : 1
stoichiometry:c57 : 1
m24*m1633*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p23
p25
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m22*m23*0.1
nodelay
--
0
PMID: 16846591 Binding of the newly secreted IFN-¦Â and IFN-alpha1 to receptors on adjacent cells leads to the activation of the Jak/STAT signaling pathway.
p26
p26
cso30:i:ME_Phosphorylation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
stoichiometry:c63 : 1
m19314*m980*m3902*m1599*0.1
nodelay
--
0
PMID: 16846591,15743772,10938111 Similarly to IRF-3, IRF-7 is activated by virus-induced phosphorylation at its C-terminus PMID: 16846591,10938111,11073981,9877175,12702806,15367631 The serine rich C-terminal region between aa471?487, is the target of virus-induced phosphorylation and by TBK1 and IKK epsilon
p27
p27
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c102 : 1
stoichiometry:c103 : 1
m17*m36*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m19325*m18*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c70 : 1
m26*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m1639*m9*0.1
nodelay
--
0
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c71 : 1
stoichiometry:c72 : 1
m27*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m28*m30*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m29*m30*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m31*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m32*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m31*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c85 : 1
stoichiometry:c86 : 1
m32*0.1
nodelay
--
0
PMID: 16846591,9822609,9541017,12213596 Active IRF-7 homodimers or heterodimers with IRF-3, bind to promoters of all IFN-alpha genes, and are thus ultimately responsible for the induction of delayed type I IFNs and amplification of the interferon response
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
m10*0.1
nodelay
--
0
PMID: 16846591,14625680 Furthermore, macrophages primed with interferon (IFN)-¦Ã increases the expression of Fc¦ÃR, inducible nitric oxide synthase (iNOS), TRAIL (TNF-related apoptosis inducing ligand), cell adhesion molecules, and production of IL-1, resulting in enhanced tumor cell killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c91 : 1
stoichiometry:c92 : 1
m10*0.1
nodelay
--
0
PMID: 16846591,14625680 Furthermore, macrophages primed with interferon (IFN)-¦Ã increases the expression of Fc¦ÃR, inducible nitric oxide synthase (iNOS), TRAIL (TNF-related apoptosis inducing ligand), cell adhesion molecules, and production of IL-1, resulting in enhanced tumor cell killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
m10*0.1
nodelay
--
0
PMID: 16846591,14625680 Furthermore, macrophages primed with interferon (IFN)-¦Ã increases the expression of Fc¦ÃR, inducible nitric oxide synthase (iNOS), TRAIL (TNF-related apoptosis inducing ligand), cell adhesion molecules, and production of IL-1, resulting in enhanced tumor cell killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
m8*0.1
nodelay
--
0
PMID: 16846591,11404376 After IFN stimulation, hundreds of cellular genes known as interferon-stimulated genes (ISGs) are transcriptionally activated
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c95 : 1
stoichiometry:c96 : 1
m10*0.1
nodelay
--
0
PMID: 16846591,14625680 Furthermore, macrophages primed with interferon (IFN)-¦Ã increases the expression of Fc¦ÃR, inducible nitric oxide synthase (iNOS), TRAIL (TNF-related apoptosis inducing ligand), cell adhesion molecules, and production of IL-1, resulting in enhanced tumor cell killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c97 : 1
stoichiometry:c98 : 1
m37*0.1
nodelay
--
0
PMID: 16846591,14625680 Furthermore, macrophages primed with interferon (IFN)-¦Ã increases the expression of Fc¦ÃR, inducible nitric oxide synthase (iNOS), TRAIL (TNF-related apoptosis inducing ligand), cell adhesion molecules, and production of IL-1, resulting in enhanced tumor cell killing
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c99 : 1
stoichiometry:c100 : 1
m7*0.1
nodelay
--
0
PMID: 16846591,12872134 As IFN-¦Â is known to upregulate p53 expression and thereby the apoptotic cellular response, it can be argued that cell death induced by Ad-IRF-3 could be mediated by IFN-alpha/¦Â
p27
p43
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c104 : 1
stoichiometry:c105 : 1
stoichiometry:c106 : 1
m19314*m36*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
p27
p44
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c107 : 1
stoichiometry:c108 : 1
stoichiometry:c109 : 1
m19314*m39*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
p27
p45
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c111 : 1
stoichiometry:c112 : 1
m17*m39*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c113 : 1
stoichiometry:c114 : 1
stoichiometry:c115 : 1
m19828*m41*0.1
nodelay
--
0
PMID: 16846591,14976261,14976262,12626561 Plasmacytoid dendritic cells (pDC) are major IFN producing cells and stand out amongst other cells in their ability to produce high amounts of IFN-greek small letter alpha/¦Â following engagement of TLR9 by unmethylated DNA or stimulation of hTLR7/mTLR8 by single stranded viral RNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c116 : 1
stoichiometry:c117 : 1
stoichiometry:c118 : 1
m43*m155901*0.1
nodelay
--
0
PMID: 16846591,14976261,14976262,12626561 Plasmacytoid dendritic cells (pDC) are major IFN producing cells and stand out amongst other cells in their ability to produce high amounts of IFN-greek small letter alpha/¦Â following engagement of TLR9 by unmethylated DNA or stimulation of hTLR7/mTLR8 by single stranded viral RNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c120 : 1
stoichiometry:c121 : 1
m43*m19823*0.1
nodelay
--
0
PMID: 16846591,14976261,14976262,12626561 Plasmacytoid dendritic cells (pDC) are major IFN producing cells and stand out amongst other cells in their ability to produce high amounts of IFN-greek small letter alpha/¦Â following engagement of TLR9 by unmethylated DNA or stimulation of hTLR7/mTLR8 by single stranded viral RNA
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c122 : 1
stoichiometry:c123 : 1
stoichiometry:c124 : 1
m1572*m42*0.1
nodelay
--
0
PMID: 16846591,15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c12 : 1
stoichiometry:c13 : 1
m7*0.1
nodelay
--
0
PMID: 16846591,11404376 After IFN stimulation, hundreds of cellular genes known as interferon-stimulated genes (ISGs) are transcriptionally activated
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c125 : 1
stoichiometry:c126 : 1
stoichiometry:c127 : 1
m44*m1572*0.1
nodelay
--
0
PMID: 16846591,15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
p51
p51
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c128 : 1
stoichiometry:c129 : 1
stoichiometry:c130 : 1
stoichiometry:c132 : 1
stoichiometry:c131 : 1
m17258*m183*m980*m46*0.1
nodelay
--
0
PMID: 16846591,14991609,15492225 Coccia et al. hypothesize that the regulation of IFN-alpha production in pDCs may not be mediated by the positive feedback effect of IFN-¦Â due to constitutive expression of IRF-7 and the ability of MyD88 to recruit IRF-7, but not IRF-3, through a molecular complex including TRAF6 and IRAK4
p51
p52
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c134 : 1
stoichiometry:c135 : 1
stoichiometry:c136 : 1
stoichiometry:c137 : 1
m47*m980*m183*m17258*0.1
nodelay
--
0
PMID: 16846591,14991609,15492225 Coccia et al. hypothesize that the regulation of IFN-alpha production in pDCs may not be mediated by the positive feedback effect of IFN-¦Â due to constitutive expression of IRF-7 and the ability of MyD88 to recruit IRF-7, but not IRF-3, through a molecular complex including TRAF6 and IRAK4
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c138 : 1
stoichiometry:c139 : 1
stoichiometry:c140 : 1
m181*m48*0.1
nodelay
--
0
PMID: 16846591,16612387 In addition, IKK-alpha associated with and phosphorylated IRF-7, thus identifying a role for IKK-alpha in the TLR7/9 signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c141 : 1
stoichiometry:c142 : 1
stoichiometry:c143 : 1
m181*m49*0.1
nodelay
--
0
PMID: 16846591,16612387 In addition, IKK-alpha associated with and phosphorylated IRF-7, thus identifying a role for IKK-alpha in the TLR7/9 signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c144 : 1
stoichiometry:c145 : 1
m63*0.1
nodelay
--
0
PMID: 16846591,16612387 In addition, IKK-alpha associated with and phosphorylated IRF-7, thus identifying a role for IKK-alpha in the TLR7/9 signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c146 : 1
stoichiometry:c147 : 1
m64*0.1
nodelay
--
0
PMID: 16846591,16612387 In addition, IKK-alpha associated with and phosphorylated IRF-7, thus identifying a role for IKK-alpha in the TLR7/9 signaling pathway
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c148 : 1
stoichiometry:c149 : 1
m48*0.1
nodelay
--
0
PMID: 16846591, 15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c156 : 1
stoichiometry:c157 : 1
stoichiometry:c158 : 1
m67*m68*0.1
nodelay
--
0
PMID: 16846591,11256746,9822609,11585785,9541017,11544356,11846975 The ISGF3 complex (ISGF3¦Ã/IRF-9-STAT1-STAT2) binds to interferon-stimulated response elements (ISRE) found in numerous IFN-induced gene promoters such as PKR, 2¡ì?5¡ì oligoadenylate synthase and IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c150 : 1
stoichiometry:c151 : 1
m48*0.1
nodelay
--
0
PMID: 16846591, 15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m11*0.1
nodelay
--
0
PMID: 16846591 These genes encode proteins such as RNase L, dsRNA-dependent protein kinase (PKR), and 2¡ì?5¡ì oligoadenylate synthetase (OAS), that mediate antiviral activities directly or indirectly.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c152 : 1
stoichiometry:c153 : 1
m66*0.1
nodelay
--
0
PMID: 16846591, 15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c155 : 1
m66*0.1
nodelay
--
0
PMID: 16846591, 15800576 pDC utilize a MyD88-dependent pathway of IFN-greek small letter alpha/¦Â induction, which is also dependent on IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c160 : 1
stoichiometry:c161 : 1
m67*m70*0.1
nodelay
--
0
PMID: 16846591,11256746,9822609,11585785,9541017,11544356,11846975 The ISGF3 complex (ISGF3¦Ã/IRF-9-STAT1-STAT2) binds to interferon-stimulated response elements (ISRE) found in numerous IFN-induced gene promoters such as PKR, 2¡ì?5¡ì oligoadenylate synthase and IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c18 : 1
stoichiometry:c163 : 1
stoichiometry:c164 : 1
m67*m72*0.1
nodelay
--
0
PMID: 16846591,11256746,9822609,11585785,9541017,11544356,11846975 The ISGF3 complex (ISGF3¦Ã/IRF-9-STAT1-STAT2) binds to interferon-stimulated response elements (ISRE) found in numerous IFN-induced gene promoters such as PKR, 2¡ì?5¡ì oligoadenylate synthase and IRF-7
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c159 : 1
stoichiometry:c17 : 1
m69*0.1
nodelay
--
0
PMID: 16846591 These genes encode proteins such as RNase L, dsRNA-dependent protein kinase (PKR), and 2¡ì?5¡ì oligoadenylate synthetase (OAS), that mediate antiviral activities directly or indirectly.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c162 : 1
stoichiometry:c19 : 1
m71*0.1
nodelay
--
0
PMID: 16846591 These genes encode proteins such as RNase L, dsRNA-dependent protein kinase (PKR), and 2¡ì?5¡ì oligoadenylate synthetase (OAS), that mediate antiviral activities directly or indirectly.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c20 : 1
stoichiometry:c21 : 1
stoichiometry:c22 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 16846591,11846975 Viral entry or engagement of TLR3 or TLR4 induces the activation of latent transcription factors involved in immunomodulation, including IRF-3, NF-¦ÊB and ATF-2/c-Jun
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--